Promising results from APDA-funded LRRK2 research

On July 25, 2018, the APDA Center for Advanced Research at the University of...see more Pittsburgh, led by the Center’s Director (and APDA Scientific Advisory Board member), Dr. J. Timothy Greenamyre, published results of a study highlighting the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease.

Read More